Long-term outcomes of percutaneous revascularization for internal mammary artery–left anterior descending artery bypass failure
暂无分享,去创建一个
T. Murohara | K. Takagi | I. Morishima | R. Yoshida | H. Ishii | A. Tanaka | Toshikazu Tanaka | M. Watarai | T. Noda | S. Yamaguchi | M. Iwama | Y. Yoshida | Miho Tanaka | Yosuke Tatami | Yusuke Uemura | Kenji Takemoto | Y. Negishi | N. Umemoto | Taiki Ohashi | K. Shimizu | Y. Takada | Nobutaka Kudo | Shogo Yamaguchi | Ruka Yoshida | Makoto Iwama | N. Kudo
[1] M. Bell,et al. Repeat Coronary Bypass Surgery or Percutaneous Coronary Intervention After Previous Surgical Revascularization. , 2019, Mayo Clinic proceedings.
[2] Yaiza Beatriz Molero-Díez,et al. Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.
[3] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[4] Volkmar Falk,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.
[5] V. Fuster,et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data , 2018, The Lancet.
[6] T. Hong,et al. Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve) , 2017, Circulation.
[7] R. Rakhit,et al. Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG. , 2017, International journal of cardiology.
[8] C. Vassanelli,et al. Repeat revascularization: Percutaneous coronary intervention after coronary artery bypass graft surgery. , 2016, Cardiovascular revascularization medicine : including molecular interventions.
[9] Deepak L. Bhatt,et al. CORONARY Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery Insights From the Veterans Affairs Clinical Assessment , Reporting , and Tracking Program , 2022 .
[10] Youjun Liu,et al. Hemodynamics of the string phenomenon in the internal thoracic artery grafted to the left anterior descending artery with moderate stenosis. , 2016, Journal of biomechanics.
[11] R. Venkateswaran,et al. Reusing the patent internal mammary artery as a conduit in redo coronary artery bypass surgery. , 2016, Interactive cardiovascular and thoracic surgery.
[12] M. Mack,et al. Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial , 2016, Circulation.
[13] Armando Pérez de Prado,et al. Immediate and Long-Term Results of Drug-Eluting Stents in Mammary Artery Grafts. , 2015, The American journal of cardiology.
[14] A. Yeung,et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. , 2015, The New England journal of medicine.
[15] D. Saba,et al. A comparison of off-pump and on-pump coronary bypass surgery in patients with low EuroSCORE , 2014, Journal of Cardiothoracic Surgery.
[16] Renu Virmani,et al. Why is the mammary artery so special and what protects it from atherosclerosis? , 2013, Annals of cardiothoracic surgery.
[17] F. Grover,et al. Repeat Coronary Revascularization After Coronary Artery Bypass Surgery in Older Adults: The Society of Thoracic Surgeons’ National Experience, 1991–2007 , 2013, Circulation.
[18] I. Édes,et al. Various clinical scenarios leading to development of the string sign of the internal thoracic artery after coronary bypass surgery: the role of competitive flow, a case series , 2012, Journal of Cardiothoracic Surgery.
[19] Sunil V. Rao,et al. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. , 2011, JACC. Cardiovascular interventions.
[20] G. Stone,et al. Saphenous vein graft intervention. , 2011, JACC. Cardiovascular interventions.
[21] Yasuhiko Tomino,et al. Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] C. Macaya,et al. Rescue percutaneous intervention for acute complications of coronary artery surgery. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[23] A. J. O’Malley,et al. Saphenous Vein Graft Stenting and Major Adverse Cardiac Events: A Predictive Model Derived From a Pooled Analysis of 3958 Patients , 2008, Circulation.
[24] K. Kent,et al. Comparison of outcomes between bare metal stents and drug-eluting stents for percutaneous revascularization of internal mammary grafts. , 2006, The American journal of cardiology.
[25] Prevent Iv Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. , 2005 .
[26] A. Pichard,et al. Clinical outcomes following stent implantation in internal mammary artery grafts , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[27] Jerome Sacks,et al. Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. , 2002, Journal of the American College of Cardiology.
[28] M. Borger,et al. The changing pattern of reoperative coronary surgery: trends in 1230 consecutive reoperations. , 2000, The Journal of thoracic and cardiovascular surgery.
[29] G. Stone,et al. Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes. , 2000, Journal of the American College of Cardiology.
[30] Akshay S. Desai,et al. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. , 2018, Journal of the American College of Cardiology.
[31] Jung‐Min Ahn,et al. Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease Data From a Prospective IRIS-FFR Registry , 2017 .
[32] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .
[33] V. Thourani,et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2012 .
[34] H. Daida,et al. String-sign in left internal thoracic artery is associated with regression in left main trunk stenosis after coronary artery bypass. , 2011, International heart journal.